IceCure Medical Ltd
ICCM
$0.9201
-$0.0311-3.27%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | 12.65% | 11.08% | 13.70% | |
| Total Depreciation and Amortization | -- | 9.93% | 19.64% | 30.24% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 9.33% | -43.16% | -43.53% | |
| Change in Net Operating Assets | -- | 719.37% | 334.84% | 144.39% | |
| Cash from Operations | -- | 24.37% | 12.03% | 12.19% | |
| Capital Expenditure | -- | 73.33% | 74.12% | 46.13% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 241.62% | 202.12% | -- | |
| Cash from Investing | -- | 229.18% | 194.08% | 23.23% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -66.84% | -79.87% | -99.43% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -64.57% | -78.49% | -99.39% | |
| Foreign Exchange rate Adjustments | -- | -3.53% | 96.69% | 107.02% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 163.44% | 132.05% | -569.01% | |